Last reviewed · How we verify

NCT06201975

Efficacy of Thyme Honey as a Novel Adjunct to Non-surgical Periodontal Therapy

Status unknown NA Last updated 11 January 2024
What this trial tests

NA trial testing Thyme honey in Periodontal Diseases in 20 participants. Status unknown.

Timeline
1 January 2024
Primary endpoint
1 February 2024
20 February 2024

Quick facts

Lead sponsorBritish University In Egypt
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment20
Start date1 January 2024
Primary completion1 February 2024
Estimated completion20 February 2024

Drugs / interventions tested

Conditions studied

Sponsor

British University In Egypt

Who can join

19 and older, any sex, with Periodontal Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Periodontal diseases are disease processes involving the periodontium, a term used to describe the supportive apparatus surrounding the tooth, which includes the gingival tissue, alveolar bone, cementum, and periodontal ligament. Thyme honey, as a conventional therapy, might be a novel antioxidant to abate many of the diseases directly or indirectly associated with oxidative stress. To the best of the researchers' knowledge, there are no published studies on the management of periodontitis in using locally delivered Thyme honey.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Thyme honey

Trials testing the same drug.

Other recruiting trials for Periodontal Diseases

Currently open trials in the same condition.

Other British University In Egypt trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06201975.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing